International platform trials: as diseases cross borders, so should trials.

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Hiroki Saito on behalf of theRandomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP) investigators

Journal title: The Lancet Infectious Diseases

Journal publisher: Elsevier

Published year: 2023

DOI identifier: 10.1016/s1473-3099(23)00193-7

ISSN: 1474-547X